Nicholas C. Robin, Ph.D.
Affiliations: | Pharmacology | University of Washington, Seattle, Seattle, WA |
Area:
Wnt signalingGoogle:
"Nicholas Robin"Mean distance: 17.6 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentorRandall Moon | grad student | 2014 | University of Washington | |
(Pharmacologic regulation of Wnt/beta-Catenin Signaling in Stem and Progenitor Cells.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Robin NC, Agoston Z, Biechele TL, et al. (2014) Simvastatin promotes adult hippocampal neurogenesis by enhancing Wnt/β-catenin signaling. Stem Cell Reports. 2: 9-17 |
James RG, Bosch KA, Kulikauskas RM, et al. (2013) Protein kinase PKN1 represses Wnt/β-catenin signaling in human melanoma cells. The Journal of Biological Chemistry. 288: 34658-70 |
Martin PM, Yang X, Robin N, et al. (2013) A rare WNT1 missense variant overrepresented in ASD leads to increased Wnt signal pathway activation. Translational Psychiatry. 3: e301 |
James RG, Davidson KC, Bosch KA, et al. (2012) WIKI4, a novel inhibitor of tankyrase and Wnt/ß-catenin signaling. Plos One. 7: e50457 |
Biechele TL, Kulikauskas RM, Toroni RA, et al. (2012) Wnt/β-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma. Science Signaling. 5: ra3 |
Biechele TL, Camp ND, Fass DM, et al. (2010) Chemical-genetic screen identifies riluzole as an enhancer of Wnt/β-catenin signaling in melanoma. Chemistry & Biology. 17: 1177-82 |